SLC5A2 and atrial fibrillation: In addition, SGLT2 inhibitors have been associated with the attenuation of inflammation, oxidative stress, and fibrosis [101]; by reducing these, SGLT2 inhibitors may help to preserve the structural and electrical integrity of the atria, thereby reducing the likelihood of AF development.